The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells

Journal of Cellular and Molecular Medicine

Volumn 21, Issue 2, 2017, Pages 387-401

  Kornicka, Katarzyna ^a,b   Marycz, Krzysztof ^a,b   Marędziak, Monika ^c   Tomaszewski, Krzysztof A ^d   Nicpoń, Jakub ^c  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b WROCLAW RESEARCH CENTRE EIT   (Poland)

^c WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

5 Azacitidine; ageing; mesenchymal stem cells; methylation; oxidative stress

Indexed keywords

AZACITIDINE; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SUPEROXIDE DISMUTASE; CULTURE MEDIUM; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA (CYTOSINE 5) METHYLTRANSFERASE; ENZYME INHIBITOR; MEMBRANE ANTIGEN; MESSENGER RNA;

ADIPOSE DERIVED STEM CELL; AGING; APOPTOSIS; ARTICLE; BRDU ASSAY; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; TRANSMISSION ELECTRON MICROSCOPY; ADIPOSE TISSUE; AGED; ANTAGONISTS AND INHIBITORS; CELL AGING; CELL CLONE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; KINETICS; MALE; METABOLISM; MIDDLE AGED; MULTIPOTENT STEM CELL; PATHOLOGY; PHARMACOLOGY; STEM CELL; ULTRASTRUCTURE;

ADIPOSE TISSUE; AGED; ANTIGENS, SURFACE; AZACITIDINE; BCL-2-ASSOCIATED X PROTEIN; CELL AGING; CELL PROLIFERATION; CLONE CELLS; CULTURE MEDIA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; HUMANS; KI-67 ANTIGEN; KINETICS; MALE; MIDDLE AGED; MULTIPOTENT STEM CELLS; OXIDATIVE STRESS; RNA, MESSENGER; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85007305792     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12972     Document Type: Article

References (49)

1. Shrestha LB. Population aging in developing countries. Health Aff Proj Hope. 2000; 19: 204–12.
2. Wolf M, Wurm A, Heinemann F, et al. The effect of patient age on bone formation using a fully synthetic nanocrystalline bone augmentation material in maxillary sinus grafting. Int J Oral Maxillofac Implants. 2014; 29: 976–83.
3. Warth A, Stenzinger A, Andrulis M, et al. Individualized medicine and demographic change as determining workload factors in pathology: quo vadis? Virchows Arch Int J Pathol. 2015; Jan;468(1): 101–8.
4. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012; 5: 19.
5. Kim N, Cho S-G. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013; 28: 387–402.
6. Patel DM, Shah J, Srivastava AS, et al. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int 2013; 2013: e496218.
7. Wei X, Yang X, Han Z, et al. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013; 34: 747–54.
8. Sarugaser R, Hanoun L, Keating A, et al. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE. 2009; 4: e6498.
9. Ren G, Chen X, Dong F, et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 2012; 1: 51–8.
10. Nicpoń J, Marycz K, Grzesiak J. Therapeutic effect of adipose-derived mesenchymal stem cell injection in horses suffering from bone spavin. Pol J Vet Sci. 2013; 16: 753–4.
11. Yoo J, Kim H-S, Hwang D-Y. Stem cells as promising therapeutic options for neurological disorders. J Cell Biochem. 2013; 114: 743–53.
12. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006; 441: 1094–6.
13. Zuk P. Adipose-derived stem cells in tissue regeneration: a review. Int Sch Res Not. 2013; 21: 1783–87.
14. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107: 1395–402.
15. Kornicka K, Marycz K, Tomaszewski KA, et al. The effect of age on osteogenic and adipogenic differentiation potential of human adipose derived stromal stem cells (hASCs) and the impact of stress factors in the course of the differentiation process. Oxidative Med Cell Longev. 2015; 2015: e309169.
16. Beane OS, Fonseca VC, Cooper LL, et al. Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells. PLoS ONE. 2014; 9: e115963.
17. Lepperdinger G. Inflammation and mesenchymal stem cell aging. Curr Opin Immunol. 2011; 23: 518–24.
18. Kasper G, Mao L, Geissler S, et al. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells Dayt Ohio. 2009; 27: 1288–97.
19. Muñoz-Najar U, Sedivy JM. Epigenetic control of aging. Antioxid Redox Signal. 2011; 14: 241–59.
20. Li J, Ohliger J, Pei M. Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective. Stem Cells Dev. 2014; 23: 1178–94.
21. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007; 2: 219–36.
22. Liu D, Xu Y. p53, oxidative stress, and aging. Antioxid Redox Signal. 2011; 15: 1669–78.
23. Masgras I, Carrera S, Verdier PJ, et al. Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem. 2012; 287: 9845–54.
24. Liu W, Song F, Ren L, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015; 19: 511–20.
25. Bentivegna A, Miloso M, Riva G, et al. DNA methylation changes during in vitro propagation of human mesenchymal stem cells: implications for their genomic stability? Stem Cells Int 2013; 2013: e192425.
26. Zhu Y, Song X, Han F, et al. Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells. PLoS ONE. 2015; 10: e0117068.
27. Kiziltepe T, Hideshima T, Catley L, et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol Cancer Ther. 2007; 6: 1718–27.
28. Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005; 97: 1498–506.
29. Sutherland MK, Yu C, Anderson M, et al. 5-Azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. MAbs. 2010; 2: 440–8.
30. Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013; 38: 23–38.
31. Seeliger C, Culmes M, Schyschka L, et al. Decrease of global methylation improves significantly hepatic differentiation of Ad-MSCs: possible future application for urea detoxification. Cell Transplant. 2013; 22: 119–31.
32. Ito S, D'Alessio AC, Taranova OV, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010; 466: 1129–33.
33. Marycz K, Śmieszek A, Grzesiak J, et al. Application of bone marrow and adipose-derived mesenchymal stem cells for testing the biocompatibility of metal-based biomaterials functionalized with ascorbic acid. Biomed Mater Bristol Engl. 2013; 8: 065004.
34. Marędziak M, Marycz K, Lewandowski D, et al. Static magnetic field enhances synthesis and secretion of membrane-derived microvesicles (MVs) rich in VEGF and BMP-2 in equine adipose-derived stromal cells (EqASCs)-a new approach in veterinary regenerative medicine. Vitro Cell Dev Biol Anim. 2015; 51: 230–40.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156–9.
36. Marędziak M, Śmieszek A, Tomaszewski KA, et al. The effect of low static magnetic field on osteogenic and adipogenic differentiation potential of human adipose stromal/stem cells. J Magn Magn Mater. 2016; 398: 235–45.
37. Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med. 2014; 20: 870–80.
38. Rodrigues M, Griffith LG, Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther. 2010; 1: 32.
39. Marinovic-Kulisic S, Juric-Lekic G, Vikic-Topic M, et al. 5-Azacytidine enhances proliferation in transplanted rat fetal epiglottis. Front Biosci Elite Ed. 2011; 3: 581–90.
40. Ratajczak J, Wysoczynski M, Hayek F, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20: 1487–95.
41. Shyh-Chang N, Zhu H, Yvanka de Soysa T, et al. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell. 2013; 155: 778–92.
42. Wanet A, Arnould T, Najimi M, et al. Connecting mitochondria, metabolism, and stem cell fate. Stem Cells Dev. 2015; 24: 1957–71.
43. Ryu JM, Lee HJ, Jung YH, et al. Regulation of stem cell fate by ROS-mediated alteration of metabolism. Int J Stem Cells. 2015; 8: 24–35.
44. Atashi F, Modarressi A, Pepper MS. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 2015; 24: 1150–63.
45. Brandl A, Meyer M, Bechmann V, et al. Oxidative stress induces senescence in human mesenchymal stem cells. Exp Cell Res. 2011; 317: 1541–7.
46. Stolzing A, Jones E, McGonagle D, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008; 129: 163–73.
47. Rui Y, Xu L, Chen R, et al. Epigenetic memory gained by priming with osteogenic induction medium improves osteogenesis and other properties of mesenchymal stem cells. Sci Rep. 2015; 5: 11056.
48. Qian Q, Qian H, Zhang X, et al. 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev 2012; 21: 67–75.
49. Yan X, Ehnert S, Culmes M, et al. 5-Azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation. PLoS ONE. 2014; 9: e90846.